Antidepressant and anxiolytic compounds isolated from Salvia elegans interact with serotonergic drugs
Salvia elegans belongs to a genus plants with biological activities in central nervous system. In this work, the purpose was to evaluate the anxiolytic and antidepressant effects of fractions and compounds isolated from S. elegans and its interaction with serotoninergic drugs by using behavioral tes...
Saved in:
Published in | Naunyn-Schmiedeberg's archives of pharmacology Vol. 394; no. 12; pp. 2419 - 2428 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Berlin/Heidelberg
Springer Berlin Heidelberg
01.12.2021
Springer Nature B.V |
Subjects | |
Online Access | Get full text |
ISSN | 0028-1298 1432-1912 1432-1912 |
DOI | 10.1007/s00210-021-02155-6 |
Cover
Abstract | Salvia elegans
belongs to a genus plants with biological activities in central nervous system. In this work, the purpose was to evaluate the anxiolytic and antidepressant effects of fractions and compounds isolated from
S. elegans
and its interaction with serotoninergic drugs by using behavioral tests in mice. Fractions from aerial parts of
S. elegans
were obtained by column chromatography, SeF1, SeF2, SeF3, and SeF4. Each of them was administered to 25 mg/k in ICR mice subject to forced swimming test (FST), or elevated plus maze test (EPM), or open field test (OFT). The most active fractions were chemically separated until compounds, which were analyzed as anxiolytic or antidepressant and the coadministration of these treatments with 5-HT
1A
and 5-HT
2
drugs was measured in the different biological tests. All fractions were anxiolytic and antidepressant, oleanolic acid (OA) was found in SeF2, and from SeF3, a mixture of terpenes was found; a GC–MS analysis confirmed the presence of two main compounds: rosifoliol and agaraspirol (TM, mixture of terpenes). TM (doses-response curve, 0.01, 0.1, 0.5, 1.0, and 2.0 mg/kg) and OA (5 mg/kg) were also evaluated demonstrating an antidepressant and anxiolytic effect, respectively. The combination of TM (0.5 mg/kg) with 8-OH (selective 5-HT
1A
receptor agonist) induced an increment of antidepressant activity, while with the antagonist WAY-100635, the effect diminished. But with DOI (5-HT
1
c/5-HT
2
receptor agonist), there was no change, and with KET (5-HT
2
receptor antagonist), the activity was increased. When OA is co-administered with 8-OH or with DOI, the anxiolytic activity of this terpene, diminished; but with the combination with antagonists, the effect of OA shows no change. TM and OA were antidepressant and anxiolytic, respectively, on mice exposed to different tests, and these are able to interact with serotoninergic drugs. |
---|---|
AbstractList | Salvia elegans belongs to a genus plants with biological activities in central nervous system. In this work, the purpose was to evaluate the anxiolytic and antidepressant effects of fractions and compounds isolated from S. elegans and its interaction with serotoninergic drugs by using behavioral tests in mice. Fractions from aerial parts of S. elegans were obtained by column chromatography, SeF1, SeF2, SeF3, and SeF4. Each of them was administered to 25 mg/k in ICR mice subject to forced swimming test (FST), or elevated plus maze test (EPM), or open field test (OFT). The most active fractions were chemically separated until compounds, which were analyzed as anxiolytic or antidepressant and the coadministration of these treatments with 5-HT
and 5-HT
drugs was measured in the different biological tests. All fractions were anxiolytic and antidepressant, oleanolic acid (OA) was found in SeF2, and from SeF3, a mixture of terpenes was found; a GC-MS analysis confirmed the presence of two main compounds: rosifoliol and agaraspirol (TM, mixture of terpenes). TM (doses-response curve, 0.01, 0.1, 0.5, 1.0, and 2.0 mg/kg) and OA (5 mg/kg) were also evaluated demonstrating an antidepressant and anxiolytic effect, respectively. The combination of TM (0.5 mg/kg) with 8-OH (selective 5-HT
receptor agonist) induced an increment of antidepressant activity, while with the antagonist WAY-100635, the effect diminished. But with DOI (5-HT
c/5-HT
receptor agonist), there was no change, and with KET (5-HT
receptor antagonist), the activity was increased. When OA is co-administered with 8-OH or with DOI, the anxiolytic activity of this terpene, diminished; but with the combination with antagonists, the effect of OA shows no change. TM and OA were antidepressant and anxiolytic, respectively, on mice exposed to different tests, and these are able to interact with serotoninergic drugs. Salvia elegans belongs to a genus plants with biological activities in central nervous system. In this work, the purpose was to evaluate the anxiolytic and antidepressant effects of fractions and compounds isolated from S. elegans and its interaction with serotoninergic drugs by using behavioral tests in mice. Fractions from aerial parts of S. elegans were obtained by column chromatography, SeF1, SeF2, SeF3, and SeF4. Each of them was administered to 25 mg/k in ICR mice subject to forced swimming test (FST), or elevated plus maze test (EPM), or open field test (OFT). The most active fractions were chemically separated until compounds, which were analyzed as anxiolytic or antidepressant and the coadministration of these treatments with 5-HT1A and 5-HT2 drugs was measured in the different biological tests. All fractions were anxiolytic and antidepressant, oleanolic acid (OA) was found in SeF2, and from SeF3, a mixture of terpenes was found; a GC-MS analysis confirmed the presence of two main compounds: rosifoliol and agaraspirol (TM, mixture of terpenes). TM (doses-response curve, 0.01, 0.1, 0.5, 1.0, and 2.0 mg/kg) and OA (5 mg/kg) were also evaluated demonstrating an antidepressant and anxiolytic effect, respectively. The combination of TM (0.5 mg/kg) with 8-OH (selective 5-HT1A receptor agonist) induced an increment of antidepressant activity, while with the antagonist WAY-100635, the effect diminished. But with DOI (5-HT1c/5-HT2 receptor agonist), there was no change, and with KET (5-HT2 receptor antagonist), the activity was increased. When OA is co-administered with 8-OH or with DOI, the anxiolytic activity of this terpene, diminished; but with the combination with antagonists, the effect of OA shows no change. TM and OA were antidepressant and anxiolytic, respectively, on mice exposed to different tests, and these are able to interact with serotoninergic drugs.Salvia elegans belongs to a genus plants with biological activities in central nervous system. In this work, the purpose was to evaluate the anxiolytic and antidepressant effects of fractions and compounds isolated from S. elegans and its interaction with serotoninergic drugs by using behavioral tests in mice. Fractions from aerial parts of S. elegans were obtained by column chromatography, SeF1, SeF2, SeF3, and SeF4. Each of them was administered to 25 mg/k in ICR mice subject to forced swimming test (FST), or elevated plus maze test (EPM), or open field test (OFT). The most active fractions were chemically separated until compounds, which were analyzed as anxiolytic or antidepressant and the coadministration of these treatments with 5-HT1A and 5-HT2 drugs was measured in the different biological tests. All fractions were anxiolytic and antidepressant, oleanolic acid (OA) was found in SeF2, and from SeF3, a mixture of terpenes was found; a GC-MS analysis confirmed the presence of two main compounds: rosifoliol and agaraspirol (TM, mixture of terpenes). TM (doses-response curve, 0.01, 0.1, 0.5, 1.0, and 2.0 mg/kg) and OA (5 mg/kg) were also evaluated demonstrating an antidepressant and anxiolytic effect, respectively. The combination of TM (0.5 mg/kg) with 8-OH (selective 5-HT1A receptor agonist) induced an increment of antidepressant activity, while with the antagonist WAY-100635, the effect diminished. But with DOI (5-HT1c/5-HT2 receptor agonist), there was no change, and with KET (5-HT2 receptor antagonist), the activity was increased. When OA is co-administered with 8-OH or with DOI, the anxiolytic activity of this terpene, diminished; but with the combination with antagonists, the effect of OA shows no change. TM and OA were antidepressant and anxiolytic, respectively, on mice exposed to different tests, and these are able to interact with serotoninergic drugs. Salvia elegans belongs to a genus plants with biological activities in central nervous system. In this work, the purpose was to evaluate the anxiolytic and antidepressant effects of fractions and compounds isolated from S. elegans and its interaction with serotoninergic drugs by using behavioral tests in mice. Fractions from aerial parts of S. elegans were obtained by column chromatography, SeF1, SeF2, SeF3, and SeF4. Each of them was administered to 25 mg/k in ICR mice subject to forced swimming test (FST), or elevated plus maze test (EPM), or open field test (OFT). The most active fractions were chemically separated until compounds, which were analyzed as anxiolytic or antidepressant and the coadministration of these treatments with 5-HT1A and 5-HT2 drugs was measured in the different biological tests. All fractions were anxiolytic and antidepressant, oleanolic acid (OA) was found in SeF2, and from SeF3, a mixture of terpenes was found; a GC–MS analysis confirmed the presence of two main compounds: rosifoliol and agaraspirol (TM, mixture of terpenes). TM (doses-response curve, 0.01, 0.1, 0.5, 1.0, and 2.0 mg/kg) and OA (5 mg/kg) were also evaluated demonstrating an antidepressant and anxiolytic effect, respectively. The combination of TM (0.5 mg/kg) with 8-OH (selective 5-HT1A receptor agonist) induced an increment of antidepressant activity, while with the antagonist WAY-100635, the effect diminished. But with DOI (5-HT1c/5-HT2 receptor agonist), there was no change, and with KET (5-HT2 receptor antagonist), the activity was increased. When OA is co-administered with 8-OH or with DOI, the anxiolytic activity of this terpene, diminished; but with the combination with antagonists, the effect of OA shows no change. TM and OA were antidepressant and anxiolytic, respectively, on mice exposed to different tests, and these are able to interact with serotoninergic drugs. Salvia elegans belongs to a genus plants with biological activities in central nervous system. In this work, the purpose was to evaluate the anxiolytic and antidepressant effects of fractions and compounds isolated from S. elegans and its interaction with serotoninergic drugs by using behavioral tests in mice. Fractions from aerial parts of S. elegans were obtained by column chromatography, SeF1, SeF2, SeF3, and SeF4. Each of them was administered to 25 mg/k in ICR mice subject to forced swimming test (FST), or elevated plus maze test (EPM), or open field test (OFT). The most active fractions were chemically separated until compounds, which were analyzed as anxiolytic or antidepressant and the coadministration of these treatments with 5-HT 1A and 5-HT 2 drugs was measured in the different biological tests. All fractions were anxiolytic and antidepressant, oleanolic acid (OA) was found in SeF2, and from SeF3, a mixture of terpenes was found; a GC–MS analysis confirmed the presence of two main compounds: rosifoliol and agaraspirol (TM, mixture of terpenes). TM (doses-response curve, 0.01, 0.1, 0.5, 1.0, and 2.0 mg/kg) and OA (5 mg/kg) were also evaluated demonstrating an antidepressant and anxiolytic effect, respectively. The combination of TM (0.5 mg/kg) with 8-OH (selective 5-HT 1A receptor agonist) induced an increment of antidepressant activity, while with the antagonist WAY-100635, the effect diminished. But with DOI (5-HT 1 c/5-HT 2 receptor agonist), there was no change, and with KET (5-HT 2 receptor antagonist), the activity was increased. When OA is co-administered with 8-OH or with DOI, the anxiolytic activity of this terpene, diminished; but with the combination with antagonists, the effect of OA shows no change. TM and OA were antidepressant and anxiolytic, respectively, on mice exposed to different tests, and these are able to interact with serotoninergic drugs. |
Author | González-Cortazar, Manases Martínez-Hernández, Gabriela Belen Jiménez-Ferrer, Enrique Vargas-Villa, Gabriela Román-Ramos, Rubén Tortoriello, Jaime Herrera-Ruiz, Maribel |
Author_xml | – sequence: 1 givenname: Gabriela Belen surname: Martínez-Hernández fullname: Martínez-Hernández, Gabriela Belen organization: Centro de Investigación Biomédica del Sur, Instituto Mexicano del Seguro Social (IMSS), Doctorado en Ciencias Biológicas Y de La Salud, División de Ciencias Biológicas Y de La Salud, Universidad Autónoma Metropolitana (UAM), Departamento de Ciencias de La Salud, División de Ciencias Biológicas Y de La Salud, Universidad Autónoma Metropolitana—Iztapalapa – sequence: 2 givenname: Enrique surname: Jiménez-Ferrer fullname: Jiménez-Ferrer, Enrique organization: Centro de Investigación Biomédica del Sur, Instituto Mexicano del Seguro Social (IMSS) – sequence: 3 givenname: Manases surname: González-Cortazar fullname: González-Cortazar, Manases organization: Centro de Investigación Biomédica del Sur, Instituto Mexicano del Seguro Social (IMSS) – sequence: 4 givenname: Rubén surname: Román-Ramos fullname: Román-Ramos, Rubén organization: Departamento de Ciencias de La Salud, División de Ciencias Biológicas Y de La Salud, Universidad Autónoma Metropolitana—Iztapalapa – sequence: 5 givenname: Jaime surname: Tortoriello fullname: Tortoriello, Jaime organization: Centro de Investigación Biomédica del Sur, Instituto Mexicano del Seguro Social (IMSS) – sequence: 6 givenname: Gabriela surname: Vargas-Villa fullname: Vargas-Villa, Gabriela organization: Centro de Investigación Biomédica del Sur, Instituto Mexicano del Seguro Social (IMSS) – sequence: 7 givenname: Maribel orcidid: 0000-0001-9056-3568 surname: Herrera-Ruiz fullname: Herrera-Ruiz, Maribel email: cibis_herj@yahoo.com.mx, maribel.herrera@imss.gob.mx organization: Centro de Investigación Biomédica del Sur, Instituto Mexicano del Seguro Social (IMSS) |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34568977$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kU1P3DAQhi20qOzS_oEeqki99JLij_gjR7SCgoTEAThbjjPZGiX21nba7r_Hy1IqceAw48M878wrvyu08MEDQp8J_k4wlmcJY0pwXdq-OK_FEVqShtGatIQu0LLMVU1oq07QKqVHjLEo2Ad0whouVCvlEsG5z66HbYSUjM-V8X2pvy6Mu-xsZcO0DbPvU-VSGE2GvhpimKo7M_52poIRNsaXoc8Qjc3VH5d_VgliyMVq3JQNfZw36SM6HsyY4NPLe4oeLi_u11f1ze2P6_X5TW2Z5LmmneXMUugoGKwYYNkNbQ8NbRRXnZCDEERIXKbSdgJaUVDgg8SGkY7Lhp2ib4e92xh-zZCynlyyMI7GQ5iTprxVWHJKVEG_vkEfwxx9cbenpCCsUbRQX16ouZug19voJhN3-t8HFoAeABtDShGGV4RgvU9JH1LSpennlLQoIvVGZF022QWfo3Hj-1J2kKZyx28g_rf9juoJLqqm-w |
CitedBy_id | crossref_primary_10_3390_molecules29020468 crossref_primary_10_3390_molecules29174070 crossref_primary_10_2174_0122103155271537231006074854 |
Cites_doi | 10.1016/0163-7258(95)00004-Z 10.1111/j.1476-5381.1987.tb11329.x 10.1016/S0040-4020(01)82208-0 10.1016/j.neuropharm.2011.09.023 10.1016/j.jep.2005.12.004 10.1177/0269881114536789 10.1021/acschemneuro.7b00443 10.1007/s40263-013-0071-0 10.1016/0024-3205(95)02242-9 10.1159/000488945 10.1007/BF02244978 10.1016/j.neubiorev.2005.03.008 10.1038/266730a0 10.1016/S2215-0366(14)70220-2 10.1007/BF00207243 10.1016/S0014-2999(03)01272-X 10.1016/0014-2999(88)90019-2 10.1176/appi.books.9780890425596 10.1111/j.1476-5381.1990.tb14706.x 10.1016/j.cbi.2006.11.006 10.1016/j.neuropharm.2011.01.025 10.1016/j.jep.2006.02.003 10.1055/s-2006-957784 10.3390/molecules181113260 10.1016/j.ejphar.2004.01.031 10.2217/npy.11.12 10.1016/S0944-7113(00)80063-X |
ContentType | Journal Article |
Copyright | The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2021 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2021. |
Copyright_xml | – notice: The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2021 – notice: 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature. – notice: The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2021. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QP 7TK 7X7 7XB 88E 8AO 8FI 8FJ 8FK ABUWG AFKRA BENPR CCPQU FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 |
DOI | 10.1007/s00210-021-02155-6 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Calcium & Calcified Tissue Abstracts Neurosciences Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central ProQuest One Community College Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest One Academic Middle East (New) ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Pharma Collection ProQuest Central China ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Neurosciences Abstracts ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic ProQuest One Academic Middle East (New) |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1432-1912 |
EndPage | 2428 |
ExternalDocumentID | 34568977 10_1007_s00210_021_02155_6 |
Genre | Journal Article |
GroupedDBID | --- -4W -56 -5G -BR -EM -Y2 -~C .55 .86 .GJ .VR 06C 06D 0R~ 0VY 199 1N0 1SB 2.D 203 28- 29M 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2P1 2VQ 2~H 30V 36B 3O- 3SX 3V. 4.4 406 408 409 40D 40E 53G 5QI 5RE 5VS 67N 67Z 6NX 78A 7X7 88E 8AO 8FI 8FJ 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AACDK AAHNG AAIAL AAJBT AAJKR AANXM AANZL AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAYIU AAYQN AAYTO AAYZH ABAKF ABBBX ABBXA ABDZT ABECU ABFTV ABHLI ABHQN ABJOX ABKCH ABKTR ABMNI ABMQK ABNWP ABPLI ABQBU ABQSL ABSXP ABTEG ABTHY ABTKH ABTMW ABULA ABUWG ABWNU ABXPI ACAOD ACBXY ACDTI ACGFS ACHSB ACHXU ACIWK ACKNC ACMDZ ACMLO ACOKC ACOMO ACPIV ACPRK ACZOJ ADBBV ADHHG ADHIR ADINQ ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADYPR ADZKW AEBTG AEFIE AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AFEXP AFGCZ AFKRA AFLOW AFQWF AFRAH AFWTZ AFZKB AGAYW AGDGC AGGDS AGJBK AGMZJ AGQEE AGQMX AGRTI AGWIL AGWZB AGYKE AHAVH AHBYD AHKAY AHMBA AHSBF AHYZX AIAKS AIGIU AIIXL AILAN AITGF AJBLW AJRNO AJZVZ AKMHD ALIPV ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AMYQR AOCGG ARMRJ AXYYD AZFZN B-. BA0 BBWZM BDATZ BENPR BGNMA BPHCQ BSONS BVXVI CAG CCPQU COF CSCUP DDRTE DL5 DNIVK DPUIP DU5 EBLON EBS EIOEI EJD EMB EMOBN EN4 EPAXT ESBYG F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ6 GQ7 GQ8 GXS H13 HF~ HG5 HG6 HMCUK HMJXF HQYDN HRMNR HVGLF HZ~ I09 I5X IHE IJ- IKXTQ ITM IWAJR IXC IZIGR IZQ I~X I~Z J-C J0Z JBSCW JCJTX JZLTJ KDC KOV KOW KPH L7B LAS LLZTM M1P M4Y MA- N2Q N9A NB0 NDZJH NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OAM P19 P2P PF0 PQQKQ PROAC PSQYO PT4 PT5 QOK QOR QOS R89 R9I RHV RIG RNI RNS ROL RPX RRX RSV RZK S16 S1Z S26 S27 S28 S3A S3B SAP SBL SBY SCLPG SDH SDM SHX SISQX SJYHP SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZN T13 T16 TSG TSK TSV TUC U2A U9L UG4 UKHRP UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WJK WK6 WK8 X7M YLTOR Z45 Z7U Z7W Z82 Z87 Z8O Z8Q Z8V Z91 ZGI ZMTXR ZOVNA ZXP ~EX AAPKM AAYXX ABBRH ABDBE ABFSG ACSTC ADHKG AEZWR AFDZB AFHIU AFOHR AGQPQ AHPBZ AHWEU AIXLP ATHPR AYFIA CITATION PHGZM PHGZT CGR CUY CVF ECM EIF NPM 7QP 7TK 7XB 8FK ABRTQ K9. PJZUB PKEHL PPXIY PQEST PQUKI PRINS 7X8 PUEGO |
ID | FETCH-LOGICAL-c375t-2bc53c2eb2ea083e07bf9de424858b67f6616702ea7cb6e962ebe5f70a31b5743 |
IEDL.DBID | 7X7 |
ISSN | 0028-1298 1432-1912 |
IngestDate | Fri Sep 05 04:34:00 EDT 2025 Sat Jul 26 00:03:08 EDT 2025 Wed Feb 19 02:27:12 EST 2025 Tue Jul 01 02:10:10 EDT 2025 Thu Apr 24 23:03:01 EDT 2025 Fri Feb 21 02:48:10 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 12 |
Keywords | Depression 5-HT drugs Anxiety Forced swim test Elevated plus maze Salvia elegans |
Language | English |
License | 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c375t-2bc53c2eb2ea083e07bf9de424858b67f6616702ea7cb6e962ebe5f70a31b5743 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0001-9056-3568 |
PMID | 34568977 |
PQID | 2597613482 |
PQPubID | 2034514 |
PageCount | 10 |
ParticipantIDs | proquest_miscellaneous_2598075218 proquest_journals_2597613482 pubmed_primary_34568977 crossref_primary_10_1007_s00210_021_02155_6 crossref_citationtrail_10_1007_s00210_021_02155_6 springer_journals_10_1007_s00210_021_02155_6 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 20211200 2021-12-00 20211201 |
PublicationDateYYYYMMDD | 2021-12-01 |
PublicationDate_xml | – month: 12 year: 2021 text: 20211200 |
PublicationDecade | 2020 |
PublicationPlace | Berlin/Heidelberg |
PublicationPlace_xml | – name: Berlin/Heidelberg – name: Germany – name: Heidelberg |
PublicationTitle | Naunyn-Schmiedeberg's archives of pharmacology |
PublicationTitleAbbrev | Naunyn-Schmiedeberg's Arch Pharmacol |
PublicationTitleAlternate | Naunyn Schmiedebergs Arch Pharmacol |
PublicationYear | 2021 |
Publisher | Springer Berlin Heidelberg Springer Nature B.V |
Publisher_xml | – name: Springer Berlin Heidelberg – name: Springer Nature B.V |
References | CryanJFValentinoRJLuckiIAssessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming testNeurosci Biobehav Rev2005295475691:CAS:528:DC%2BD2MXltFWlurg%3D10.1016/j.neubiorev.2005.03.008 Villalobos-OsorioDRamírez-GonzálezIRojas-FermínLSantiago-SilvaBCarmona- ArzolaJAvedaño-MezaMComposición del aceite esencial y caracterización fisicoquímica de las hojas de Stachytarpheta mutabilis (Jacq.) VahlAv Quím201491519 CeladaPPuigMAmargós-BoschMAdellAArtigasFThe therapeutic role of 5-HT1A and 5-HT2A receptors in depressionJ Psychiatry Neurosci20042925226515309042446220 DubovskySLWhats is new about new antidepressants?Psychother Psychosom20188712913910.1159/000488945 CeladaPBortolozziAArtigasFSerotonin 5-HT1A receptors as targets for agents to treat psychiatric disorders: rationale and current status of researchCNS Drugs2013277037161:CAS:528:DC%2BC3sXhvVSmsbbN10.1007/s40263-013-0071-0 Newman-TancrediBiased agonism at serotonin 5-HT1A receptors: preferential postsynaptic activity for improved therapy of CNS disordersNeuropsychiatry2011114916410.2217/npy.11.12 HutsonPHDourishCTCurzonGEvidence that the hyperphagic response to 8-OH-DPAT is mediated by 5-HT1A receptorsEur J Pharmacol19881503613661:CAS:528:DyaL1cXkvVKisb0%3D10.1016/0014-2999(88)90019-2 CritchleyMAHandleySLEffects in the X-maze anxiety model of agents acting at 5-HT1 and 5-HT2 receptorsPsychopharmacology1987935025061:CAS:528:DyaL1cXmvVOlsw%3D%3D10.1007/BF00207243 PorsoltRDPichonMLJalifMDepression: a new model sensitive to the antidepressant treatmentNature19772667307321:CAS:528:DyaE2sXkvFGhur4%3D10.1038/266730a0 RosaADeianaMAtzeriACoronaGIncaniAMelisMPAppendinoGDessìMAEvaluation of the antioxidant and cytotoxic activity of arzanol, a prenylated alpha-pyrone-phloroglucinol etherodimer from Helichrysum italicum subsp. microphyllumChem-Biol Interact20071651171261:CAS:528:DC%2BD2sXls1eiuw%3D%3D10.1016/j.cbi.2006.11.006 HedlundPBKellyLMazurCLovenbergTSutcliffeJGBonaventureP8-OH-DPAT acts on both 5-HT1A and 5-HT7 receptors to induce hypothermia in rodentsEur J Pharmacol20044871251321:CAS:528:DC%2BD2cXitFeiu7s%3D10.1016/j.ejphar.2004.01.031 Jastrzębska-WięsekMPartykaARychtykJŚniecikowskaJKołaczkowskiMWesołowskaAVarneyMANewman-TancrediAActivity of serotonin 5-HT1A receptor biased agonists in rat: anxiolytic and antidepressant-like propertiesACS Chem Neurosci201891040105010.1021/acschemneuro.7b00443 HeerleinAAntidepressant pharmacologic treatmentsRev Chil Neuro-Psiquiat2002403951 PrutLBelzungCThe open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a reviewEur J Pharmacol20034633331:CAS:528:DC%2BD3sXhsVanu70%3D10.1016/S0014-2999(03)01272-X Aguilar A, Camacho J, Chino S, Jácquez P, López E (1994) Herbario de Medicina del Instituto Mexicano del Seguro Social. Información etnobotánica. México: Instituto Mexicano del Seguro Social pp. 159, 245. DiazSMaroteauxLImplication of 5-HT(2B) receptors in the serotonin syndromeNeuropharmacol2011614955021:CAS:528:DC%2BC3MXntFWiu78%3D10.1016/j.neuropharm.2011.01.025 MottaVMaisonnetteSMoratoSCastrechiniPBrandãoMLEffects of blockade of 5-HT2 receptors and activation of 5-HT1A receptors on the exploratory activity of rats in the elevated plus-mazePsychopharmacology19921071351391:CAS:528:DyaK38Xit1yrsLk%3D10.1007/BF02244978 MarkouACryanJFStress, anxiety and depression: toward new treatment strategiesNeuropharmacology201262121:CAS:528:DC%2BC3MXhtlaktL3E10.1016/j.neuropharm.2011.09.023 ListerRGThe use of a plus-maze to measure anxiety in the mousePsychopharmacology1987921801851:CAS:528:DyaL2sXktlejurc%3D3110839 VarmaKRMaheshwariMLBhattacharyyaSCTerpenoids-LXII: The constitution of agarospirol, a sesquiterpenoid with a new skeletonTetrahedron1965211151381:CAS:528:DyaF2MXksVSksQ%3D%3D10.1016/S0040-4020(01)82208-0 World Health OrganizationReport: depression and other common metal disorders2017GenevaGlobal Health Estimates DSM-V. American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders (5th ed.). https://doi.org/10.1176/appi.books.9780890425596 OkugawaHUedaRMatsumotoKKawanishiKKatoKEffects of sesquiterpenoids from “Oriental incenses” on acetic acid-induced writhing and D2 and 5-HT2A receptors in rat brainPhytomedicine200074174221:CAS:528:DC%2BD3cXoslWis7o%3D10.1016/S0944-7113(00)80063-X Van HeeringenKMannJJThe Neurobiology of SuicideLancet Psychiatry20141637210.1016/S2215-0366(14)70220-2 FajemiroyeJOGaldinoPMFlorentinoIRDa RochaFFGhediniPCPolepallyPRZjawionyJKCostaEAPlurality of anxiety and depression alteration mechanism by oleanolic acidJ Psychopharmacol2014892393410.1177/0269881114536789 MoserPCTricklebankMDMiddlemissDNMirAKHibertMFFozardJRCharacterization of MDL 73005EF as a 5-HT1A selective ligand and its effects in animal models of anxiety: comparison with buspirone, 8-OH-DPAT and diazepamBr J Pharmacol1990993433491:CAS:528:DyaK3cXhsFWlsrY%3D10.1111/j.1476-5381.1990.tb14706.x González-CortazarMMaldonado-AbarcaAMJiménez-FerrerEMarquinaSVentura- ZapataEZamilpaATortorielloJHerrera-RuizMIsosakuranetina- 5-O- rutinoside: a new flavanone with antidepressant activity isolated from Salvia elegans VahlMolecules201318132601327010.3390/molecules181113260 OnaiviESBishop-RobinsonCDarmaniNASandres-BushEBehavioral effects of (+/)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane, (DOI) in the elevated plus- maze testLife Sci199557245524661:CAS:528:DyaK2MXpsFemtr4%3D10.1016/0024-3205(95)02242-9 CristJSurprenantAEvidence that 8-hydroxy-2-(n-dipropylamino) tetralin (8-OH-DPAT) is a selective α2-adrenoceptor antagonist on guinea-pig submucous neuronsBr J Pharmacol1987923413471:CAS:528:DyaL2sXlvFSqsb8%3D10.1111/j.1476-5381.1987.tb11329.x OkugawaHUedaRMatsumotoKKawanishiKKayoAEffect of Jnokoh- eremol and Agarospirol from Agarwood on the central nervous system in micePlanta Med1995622610.1055/s-2006-957784 MoraSMillánRLungenstrassHDíaz-VélizGMoránJAHerrera-RuizMTortorielloJThe hydroalcoholic extract of Salvia elegans induces anxiolytic- and antidepressant-like effects in ratsJ Ethnopharmacol200610676811:STN:280:DC%2BD283otl2lsA%3D%3D10.1016/j.jep.2005.12.004 HandleySL5-hydroxytryptamine pathways in anxiety and its treatmentPharmacol Ther1995661031481:CAS:528:DyaK2MXoslCnt7k%3D10.1016/0163-7258(95)00004-Z Herrera-RuizMGarcíaYMoraSDíazGVianaSTortorielloJRamírezGAntidepressant and anxiolytic effects of hydroalcoholic extract from Salvia elegansJ Ethnopharmacol2006107535810.1016/j.jep.2006.02.003 P Celada (2155_CR3) 2013; 27 S Diaz (2155_CR7) 2011; 61 Newman-Tancredi (2155_CR23) 2011; 1 JF Cryan (2155_CR6) 2005; 29 H Okugawa (2155_CR24) 1995; 62 M Herrera-Ruiz (2155_CR15) 2006; 107 2155_CR1 V Motta (2155_CR22) 1992; 107 J Crist (2155_CR4) 1987; 92 World Health Organization (2155_CR33) 2017 M González-Cortazar (2155_CR11) 2013; 18 2155_CR8 PH Hutson (2155_CR16) 1988; 150 A Rosa (2155_CR29) 2007; 165 A Markou (2155_CR19) 2012; 62 SL Dubovsky (2155_CR9) 2018; 87 SL Handley (2155_CR12) 1995; 66 MA Critchley (2155_CR5) 1987; 93 RD Porsolt (2155_CR27) 1977; 266 M Jastrzębska-Więsek (2155_CR17) 2018; 9 JO Fajemiroye (2155_CR10) 2014; 8 L Prut (2155_CR28) 2003; 463 ES Onaivi (2155_CR26) 1995; 57 PB Hedlund (2155_CR13) 2004; 487 P Celada (2155_CR2) 2004; 29 A Heerlein (2155_CR14) 2002; 40 PC Moser (2155_CR21) 1990; 99 KR Varma (2155_CR31) 1965; 21 K Van Heeringen (2155_CR30) 2014; 1 RG Lister (2155_CR18) 1987; 92 H Okugawa (2155_CR25) 2000; 7 S Mora (2155_CR20) 2006; 106 D Villalobos-Osorio (2155_CR32) 2014; 9 |
References_xml | – reference: DubovskySLWhats is new about new antidepressants?Psychother Psychosom20188712913910.1159/000488945 – reference: HutsonPHDourishCTCurzonGEvidence that the hyperphagic response to 8-OH-DPAT is mediated by 5-HT1A receptorsEur J Pharmacol19881503613661:CAS:528:DyaL1cXkvVKisb0%3D10.1016/0014-2999(88)90019-2 – reference: PorsoltRDPichonMLJalifMDepression: a new model sensitive to the antidepressant treatmentNature19772667307321:CAS:528:DyaE2sXkvFGhur4%3D10.1038/266730a0 – reference: Newman-TancrediBiased agonism at serotonin 5-HT1A receptors: preferential postsynaptic activity for improved therapy of CNS disordersNeuropsychiatry2011114916410.2217/npy.11.12 – reference: Jastrzębska-WięsekMPartykaARychtykJŚniecikowskaJKołaczkowskiMWesołowskaAVarneyMANewman-TancrediAActivity of serotonin 5-HT1A receptor biased agonists in rat: anxiolytic and antidepressant-like propertiesACS Chem Neurosci201891040105010.1021/acschemneuro.7b00443 – reference: HandleySL5-hydroxytryptamine pathways in anxiety and its treatmentPharmacol Ther1995661031481:CAS:528:DyaK2MXoslCnt7k%3D10.1016/0163-7258(95)00004-Z – reference: Aguilar A, Camacho J, Chino S, Jácquez P, López E (1994) Herbario de Medicina del Instituto Mexicano del Seguro Social. Información etnobotánica. México: Instituto Mexicano del Seguro Social pp. 159, 245. – reference: CryanJFValentinoRJLuckiIAssessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming testNeurosci Biobehav Rev2005295475691:CAS:528:DC%2BD2MXltFWlurg%3D10.1016/j.neubiorev.2005.03.008 – reference: HedlundPBKellyLMazurCLovenbergTSutcliffeJGBonaventureP8-OH-DPAT acts on both 5-HT1A and 5-HT7 receptors to induce hypothermia in rodentsEur J Pharmacol20044871251321:CAS:528:DC%2BD2cXitFeiu7s%3D10.1016/j.ejphar.2004.01.031 – reference: ListerRGThe use of a plus-maze to measure anxiety in the mousePsychopharmacology1987921801851:CAS:528:DyaL2sXktlejurc%3D3110839 – reference: PrutLBelzungCThe open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a reviewEur J Pharmacol20034633331:CAS:528:DC%2BD3sXhsVanu70%3D10.1016/S0014-2999(03)01272-X – reference: DiazSMaroteauxLImplication of 5-HT(2B) receptors in the serotonin syndromeNeuropharmacol2011614955021:CAS:528:DC%2BC3MXntFWiu78%3D10.1016/j.neuropharm.2011.01.025 – reference: OkugawaHUedaRMatsumotoKKawanishiKKatoKEffects of sesquiterpenoids from “Oriental incenses” on acetic acid-induced writhing and D2 and 5-HT2A receptors in rat brainPhytomedicine200074174221:CAS:528:DC%2BD3cXoslWis7o%3D10.1016/S0944-7113(00)80063-X – reference: OnaiviESBishop-RobinsonCDarmaniNASandres-BushEBehavioral effects of (+/)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane, (DOI) in the elevated plus- maze testLife Sci199557245524661:CAS:528:DyaK2MXpsFemtr4%3D10.1016/0024-3205(95)02242-9 – reference: CritchleyMAHandleySLEffects in the X-maze anxiety model of agents acting at 5-HT1 and 5-HT2 receptorsPsychopharmacology1987935025061:CAS:528:DyaL1cXmvVOlsw%3D%3D10.1007/BF00207243 – reference: MoserPCTricklebankMDMiddlemissDNMirAKHibertMFFozardJRCharacterization of MDL 73005EF as a 5-HT1A selective ligand and its effects in animal models of anxiety: comparison with buspirone, 8-OH-DPAT and diazepamBr J Pharmacol1990993433491:CAS:528:DyaK3cXhsFWlsrY%3D10.1111/j.1476-5381.1990.tb14706.x – reference: CeladaPPuigMAmargós-BoschMAdellAArtigasFThe therapeutic role of 5-HT1A and 5-HT2A receptors in depressionJ Psychiatry Neurosci20042925226515309042446220 – reference: OkugawaHUedaRMatsumotoKKawanishiKKayoAEffect of Jnokoh- eremol and Agarospirol from Agarwood on the central nervous system in micePlanta Med1995622610.1055/s-2006-957784 – reference: RosaADeianaMAtzeriACoronaGIncaniAMelisMPAppendinoGDessìMAEvaluation of the antioxidant and cytotoxic activity of arzanol, a prenylated alpha-pyrone-phloroglucinol etherodimer from Helichrysum italicum subsp. microphyllumChem-Biol Interact20071651171261:CAS:528:DC%2BD2sXls1eiuw%3D%3D10.1016/j.cbi.2006.11.006 – reference: HeerleinAAntidepressant pharmacologic treatmentsRev Chil Neuro-Psiquiat2002403951 – reference: VarmaKRMaheshwariMLBhattacharyyaSCTerpenoids-LXII: The constitution of agarospirol, a sesquiterpenoid with a new skeletonTetrahedron1965211151381:CAS:528:DyaF2MXksVSksQ%3D%3D10.1016/S0040-4020(01)82208-0 – reference: CristJSurprenantAEvidence that 8-hydroxy-2-(n-dipropylamino) tetralin (8-OH-DPAT) is a selective α2-adrenoceptor antagonist on guinea-pig submucous neuronsBr J Pharmacol1987923413471:CAS:528:DyaL2sXlvFSqsb8%3D10.1111/j.1476-5381.1987.tb11329.x – reference: MarkouACryanJFStress, anxiety and depression: toward new treatment strategiesNeuropharmacology201262121:CAS:528:DC%2BC3MXhtlaktL3E10.1016/j.neuropharm.2011.09.023 – reference: Villalobos-OsorioDRamírez-GonzálezIRojas-FermínLSantiago-SilvaBCarmona- ArzolaJAvedaño-MezaMComposición del aceite esencial y caracterización fisicoquímica de las hojas de Stachytarpheta mutabilis (Jacq.) VahlAv Quím201491519 – reference: FajemiroyeJOGaldinoPMFlorentinoIRDa RochaFFGhediniPCPolepallyPRZjawionyJKCostaEAPlurality of anxiety and depression alteration mechanism by oleanolic acidJ Psychopharmacol2014892393410.1177/0269881114536789 – reference: CeladaPBortolozziAArtigasFSerotonin 5-HT1A receptors as targets for agents to treat psychiatric disorders: rationale and current status of researchCNS Drugs2013277037161:CAS:528:DC%2BC3sXhvVSmsbbN10.1007/s40263-013-0071-0 – reference: DSM-V. American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders (5th ed.). https://doi.org/10.1176/appi.books.9780890425596 – reference: MoraSMillánRLungenstrassHDíaz-VélizGMoránJAHerrera-RuizMTortorielloJThe hydroalcoholic extract of Salvia elegans induces anxiolytic- and antidepressant-like effects in ratsJ Ethnopharmacol200610676811:STN:280:DC%2BD283otl2lsA%3D%3D10.1016/j.jep.2005.12.004 – reference: MottaVMaisonnetteSMoratoSCastrechiniPBrandãoMLEffects of blockade of 5-HT2 receptors and activation of 5-HT1A receptors on the exploratory activity of rats in the elevated plus-mazePsychopharmacology19921071351391:CAS:528:DyaK38Xit1yrsLk%3D10.1007/BF02244978 – reference: Van HeeringenKMannJJThe Neurobiology of SuicideLancet Psychiatry20141637210.1016/S2215-0366(14)70220-2 – reference: World Health OrganizationReport: depression and other common metal disorders2017GenevaGlobal Health Estimates – reference: González-CortazarMMaldonado-AbarcaAMJiménez-FerrerEMarquinaSVentura- ZapataEZamilpaATortorielloJHerrera-RuizMIsosakuranetina- 5-O- rutinoside: a new flavanone with antidepressant activity isolated from Salvia elegans VahlMolecules201318132601327010.3390/molecules181113260 – reference: Herrera-RuizMGarcíaYMoraSDíazGVianaSTortorielloJRamírezGAntidepressant and anxiolytic effects of hydroalcoholic extract from Salvia elegansJ Ethnopharmacol2006107535810.1016/j.jep.2006.02.003 – volume: 66 start-page: 103 year: 1995 ident: 2155_CR12 publication-title: Pharmacol Ther doi: 10.1016/0163-7258(95)00004-Z – ident: 2155_CR1 – volume: 92 start-page: 341 year: 1987 ident: 2155_CR4 publication-title: Br J Pharmacol doi: 10.1111/j.1476-5381.1987.tb11329.x – volume: 21 start-page: 115 year: 1965 ident: 2155_CR31 publication-title: Tetrahedron doi: 10.1016/S0040-4020(01)82208-0 – volume: 62 start-page: 1 year: 2012 ident: 2155_CR19 publication-title: Neuropharmacology doi: 10.1016/j.neuropharm.2011.09.023 – volume: 106 start-page: 76 year: 2006 ident: 2155_CR20 publication-title: J Ethnopharmacol doi: 10.1016/j.jep.2005.12.004 – volume: 8 start-page: 923 year: 2014 ident: 2155_CR10 publication-title: J Psychopharmacol doi: 10.1177/0269881114536789 – volume: 9 start-page: 1040 year: 2018 ident: 2155_CR17 publication-title: ACS Chem Neurosci doi: 10.1021/acschemneuro.7b00443 – volume: 27 start-page: 703 year: 2013 ident: 2155_CR3 publication-title: CNS Drugs doi: 10.1007/s40263-013-0071-0 – volume: 57 start-page: 2455 year: 1995 ident: 2155_CR26 publication-title: Life Sci doi: 10.1016/0024-3205(95)02242-9 – volume: 87 start-page: 129 year: 2018 ident: 2155_CR9 publication-title: Psychother Psychosom doi: 10.1159/000488945 – volume: 107 start-page: 135 year: 1992 ident: 2155_CR22 publication-title: Psychopharmacology doi: 10.1007/BF02244978 – volume: 29 start-page: 547 year: 2005 ident: 2155_CR6 publication-title: Neurosci Biobehav Rev doi: 10.1016/j.neubiorev.2005.03.008 – volume: 266 start-page: 730 year: 1977 ident: 2155_CR27 publication-title: Nature doi: 10.1038/266730a0 – volume: 1 start-page: 63 year: 2014 ident: 2155_CR30 publication-title: Lancet Psychiatry doi: 10.1016/S2215-0366(14)70220-2 – volume: 40 start-page: 39 year: 2002 ident: 2155_CR14 publication-title: Rev Chil Neuro-Psiquiat – volume: 93 start-page: 502 year: 1987 ident: 2155_CR5 publication-title: Psychopharmacology doi: 10.1007/BF00207243 – volume: 463 start-page: 3 year: 2003 ident: 2155_CR28 publication-title: Eur J Pharmacol doi: 10.1016/S0014-2999(03)01272-X – volume: 150 start-page: 361 year: 1988 ident: 2155_CR16 publication-title: Eur J Pharmacol doi: 10.1016/0014-2999(88)90019-2 – ident: 2155_CR8 doi: 10.1176/appi.books.9780890425596 – volume: 92 start-page: 180 year: 1987 ident: 2155_CR18 publication-title: Psychopharmacology – volume: 99 start-page: 343 year: 1990 ident: 2155_CR21 publication-title: Br J Pharmacol doi: 10.1111/j.1476-5381.1990.tb14706.x – volume: 165 start-page: 117 year: 2007 ident: 2155_CR29 publication-title: Chem-Biol Interact doi: 10.1016/j.cbi.2006.11.006 – volume: 61 start-page: 495 year: 2011 ident: 2155_CR7 publication-title: Neuropharmacol doi: 10.1016/j.neuropharm.2011.01.025 – volume: 107 start-page: 53 year: 2006 ident: 2155_CR15 publication-title: J Ethnopharmacol doi: 10.1016/j.jep.2006.02.003 – volume: 9 start-page: 15 year: 2014 ident: 2155_CR32 publication-title: Av Quím – volume: 62 start-page: 2 year: 1995 ident: 2155_CR24 publication-title: Planta Med doi: 10.1055/s-2006-957784 – volume: 18 start-page: 13260 year: 2013 ident: 2155_CR11 publication-title: Molecules doi: 10.3390/molecules181113260 – volume-title: Report: depression and other common metal disorders year: 2017 ident: 2155_CR33 – volume: 487 start-page: 125 year: 2004 ident: 2155_CR13 publication-title: Eur J Pharmacol doi: 10.1016/j.ejphar.2004.01.031 – volume: 1 start-page: 149 year: 2011 ident: 2155_CR23 publication-title: Neuropsychiatry doi: 10.2217/npy.11.12 – volume: 29 start-page: 252 year: 2004 ident: 2155_CR2 publication-title: J Psychiatry Neurosci – volume: 7 start-page: 417 year: 2000 ident: 2155_CR25 publication-title: Phytomedicine doi: 10.1016/S0944-7113(00)80063-X |
SSID | ssj0006155 |
Score | 2.3505752 |
Snippet | Salvia elegans
belongs to a genus plants with biological activities in central nervous system. In this work, the purpose was to evaluate the anxiolytic and... Salvia elegans belongs to a genus plants with biological activities in central nervous system. In this work, the purpose was to evaluate the anxiolytic and... |
SourceID | proquest pubmed crossref springer |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 2419 |
SubjectTerms | Agonists Animals Anti-Anxiety Agents - administration & dosage Anti-Anxiety Agents - isolation & purification Anti-Anxiety Agents - pharmacology Antidepressants Antidepressive Agents - administration & dosage Antidepressive Agents - isolation & purification Antidepressive Agents - pharmacology Behavior, Animal - drug effects Biomedical and Life Sciences Biomedicine Central nervous system Column chromatography Disease Models, Animal Dose-Response Relationship, Drug Drug interaction Drug Interactions Drugs Male Maze Learning - drug effects Mice Mice, Inbred ICR Neurosciences Oleanolic acid Open-field behavior Original Article Pharmacology/Toxicology Plant Extracts - administration & dosage Plant Extracts - pharmacology Salvia - chemistry Salvia elegans Serotonin Serotonin Agents - administration & dosage Serotonin Agents - pharmacology Serotonin S1 receptors Serotonin S2 receptors Swimming Terpenes |
SummonAdditionalLinks | – databaseName: SpringerLink Journals (ICM) dbid: U2A link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3dS8MwEA86X3wRv61OiSB7cYW0adr0cYhjCMrADfZWkjaVwthk3cT99971a8hU8KF9SdKU3DX3S-_ud4TcGcljDdDWNhzdjG7KbOmHic012GbO05Br_DXw_OIPxt7TREyqpLC8jnavXZLFTt0kuxXHExtDCtBOCdvfJXsC-aRAi8dur9l_0dNWcy-DNZNVqszPz_hujrYw5pZ_tDA7_UNyUOFF2isFfER2zOyYdIYl4fS6S0eb_Km8Szt0uKGiXp8QrIOQVcGusIRUzRK4PrP5dA0DKMaTY1mlnGaggoA6E4rpJvRVTT8yRbEkBVgyipQSmExF8actBZ2dI4P3AvZMmixWb_kpGfcfRw8DuyqsYMc8EEvb1bHgsQuHaqMAghkW6DRMjIf0ZlL7QQpG2w8YtAax9k3oQ1cj0oAp7mgBmOOMtGYw0QWhTDtJrFjKEm280JFSx6EjVMATJxWKuRZx6vWN4op1HItfTKOGL7mQSQS3qJBJ5FvkvhnzXnJu_Nm7XYstqr6_PIJDXQBAxZPwArdNM3w56A5RMzNfFX2QiRkwjkXOS3E303HAlRKgsUW6tfw3D__9XS7_1_2K7Luoi0V0TJu0louVuQaMs9Q3hUp_AY9q8g8 priority: 102 providerName: Springer Nature |
Title | Antidepressant and anxiolytic compounds isolated from Salvia elegans interact with serotonergic drugs |
URI | https://link.springer.com/article/10.1007/s00210-021-02155-6 https://www.ncbi.nlm.nih.gov/pubmed/34568977 https://www.proquest.com/docview/2597613482 https://www.proquest.com/docview/2598075218 |
Volume | 394 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da9swED-69mUvY1v34a0tKoy-LGK2FfnjaaQjbWlZCVsD2ZPRl0cgJF2cjOW_350iO4yyPtgGW7aE7qz7Sbr7HcAHVwijEdpyJ2ibMa1jXmSl5UKjbRaiLoWmpYGvt9nVuH89kZOw4NYEt8p2TPQDtV0YWiP_hDAdZ9xExfL5_henrFG0uxpSaDyBgwSRCKVuyCfdhIustWxZmNGuFSFoxofO-ckOJwcFsnqSZ_8apgdo88FOqTdAF8_hWUCObLAV9QvYc_OXcDbaUk9veuxuF0nV9NgZG-1IqTeHQBkRpsHtFTuTqbnF4890MdvgC4w8yynBUsOmqIyIPy2jwBP2Xc1-TxWj5BRo0xiRS1BYFaPlW4bauyAu7yWOnswu1z-bVzC-GN59ueIhxQI3IpcrnmojhUlxeu0UgjEX57ouresT0Vmhs7xG853lMT7Njc5cmWFRJ-s8ViLREtHHa9ifY0VvgcU6sUbFdWy165dJUWhTJlLlwia1VHEaQdL2b2UC_zilwZhVHXOyl0mFp8rLpMoi-Ni9c79l33i09FErtir8iU2105sITrvH-A_Rxoiau8XalyFOZkQ7EbzZirurTiDCLBAkR9Br5b_7-P_b8u7xtryHpynpnveLOYL91XLtjhHdrPSJV-ETOBhc_rgZ4vV8eDv6hnfH6eAvwAj5Xg |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB6V9AAXxBvTAosEvZAVtjd-HSrEo1VK2yiCVOrN7MsoUpS0cQLkz_HbmNmsHaGK3nqwL14_5Nnd79udmW8AXttcaIXUlltBbsa4CnmeFoYLhdgsRFUIRVsDp4O0f9b7cp6cb8GfJheGwiqbOdFN1GamaY_8HdJ0XHGTFMv7i0tOVaPIu9qU0JC-tILZdxJjPrHj2K5-4RKu3j_6jPZ-E8eHB6NPfe6rDHAtsmTBY6UToWNcYVqJfMSGmaoKY3uk9ZWrNKsQwdIsxKuZVqktUmxqkyoLpYhUggCMz70F2z3aQOnA9seDwfBriwXk9Wt0oBFZc5-245L33HKLU4gE4W7C03-h8QrfveKrdRB4eA_ueu7KPqw7233YstMHsDdci1-vumy0yeWqu2yPDTey2KuHQDUZxj7wFs3J5NTg8Xs8m6zwBkax7VTiqWZjHA7IgA2j1Bf2TU5-jiWj8hiIqozkLSixi9EGMsPxMyM18TnO38zMlz_qR3B2I7__MXSm-KKnwEIVGS3DKjTK9oooz5UuokRmwkRVIsM4gKj5v6X2CuhUiGNSttrNziYlnkpnkzIN4G17z8Va_-Pa1ruN2Uo_F9TlpucG8Kq9jKOYXDNyamdL14ZUoZFvBfBkbe72dQI5bo40PYBuY__Nw___Lc-u_5aXcLs_Oj0pT44GxztwJ6Z-6KJ0dqGzmC_tc-RaC_XCd2gG3296DP0FOKw5Ag |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB6VVkJcKsrTpYVFgl7IqrY3fh0qBLRRSyGKoJV6M_tyFSlK2jgB8hf5Vcxs1o5QRW892BevH_Ls7HyzM_MNwBubC60Q2nIrKMwYVyHP08JwodA2C1EVQtHWwNd-enze_XyRXKzBn6YWhtIqmzXRLdRmommPfB9hOnrcRMWyX_m0iMFh7_3VNacOUhRpbdppSN9mwRw4ujFf5HFqF7_QnasPTg5R9m_juHd09umY-44DXIssmfFY6UToGL1NKxGb2DBTVWFsl3i_cpVmFVqzNAvxaqZVaosUh9qkykIpIpWgMcbn3oONDK0-OoIbH4_6g2-tXaAIYMMJjVY29yU8rpDPuV6c0iXIBic8_ddM3sC-N-K2zhz2HsKmx7Hsw3LibcGaHT-CvcGSCHvRYWeruq66w_bYYEWRvXgM1J9h6JNwUbRMjg0ev4eT0QJvYJTnTu2eajZE1UA0bBiVwbDvcvRzKBm1ykALy4jqgoq8GG0mM9SlCTGLT3EtZ2Y6v6yfwPmd_P6nsD7GFz0HFqrIaBlWoVG2W0R5rnQRJTITJqoSGcYBRM3_LbVnQ6emHKOy5XF2MinxVDqZlGkA79p7rpZcILeO3mnEVvp1oS5XsziA1-1l1GgK08ixnczdGGKIRuwVwLOluNvXCcS7OUL2ADqN_FcP__-3bN_-La_gPupS-eWkf_oCHsQ0DV3Czg6sz6Zzu4uwa6Ze-vnM4Mddq9BfDFk9Rg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Antidepressant+and+anxiolytic+compounds+isolated+from+Salvia+elegans+interact+with+serotonergic+drugs&rft.jtitle=Naunyn-Schmiedeberg%27s+archives+of+pharmacology&rft.au=Mart%C3%ADnez-Hern%C3%A1ndez%2C+Gabriela+Belen&rft.au=Jim%C3%A9nez-Ferrer%2C+Enrique&rft.au=Gonz%C3%A1lez-Cortazar%2C+Manases&rft.au=Rom%C3%A1n-Ramos%2C+Rub%C3%A9n&rft.date=2021-12-01&rft.eissn=1432-1912&rft.volume=394&rft.issue=12&rft.spage=2419&rft_id=info:doi/10.1007%2Fs00210-021-02155-6&rft_id=info%3Apmid%2F34568977&rft.externalDocID=34568977 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0028-1298&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0028-1298&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0028-1298&client=summon |